14 Sep, 2020 RNAi Roundtable: Givosiran, for the Treatment of Acute Hepatic Porphyria

On September 14, 2020, we hosted an online RNAi Roundtable to review progress with givosiran, an RNAi therapeutic for the treatment of acute hepatic porphyria.

Access the replay
View the presentation

Akin Akinc, Ph.D.
Vice President & General Manager, Givosiran

Gail Hartigan
Senior Director, U.S. Business Lead

Amy Simon, M.D.
Vice President, Clinical Research